| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/17/2004 | WO2004050847A2 Modified antibodies stably produced in milk and methods of producing same |
| 06/17/2004 | WO2004050846A2 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
| 06/17/2004 | WO2004050833A2 Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception |
| 06/17/2004 | WO2004050679A2 Mutant glycoproteins |
| 06/17/2004 | WO2004023509A3 Metalized polyester film with heat-seal layer on opposite side for flyback transformer application |
| 06/17/2004 | WO2004011609A3 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 06/17/2004 | WO2003102138A3 Elongase genes and uses thereof |
| 06/17/2004 | WO2003059259A3 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 06/17/2004 | WO2003032810A3 Treatment and diagnosis of insulin resistant states |
| 06/17/2004 | WO2003018632A3 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 06/17/2004 | WO2003017992A3 Means for treatment of atherosclerosis |
| 06/17/2004 | US20040116672 Human sel-10 polypeptides and polynucleotides that encode them |
| 06/17/2004 | US20040116662 Comprises viral glycoprotein fusion with glutathione s-tranferase (GST) or thioredoxin for use as diagnostic tool in screening blood products for retroviral infection |
| 06/17/2004 | US20040116652 Method for producing and using novel human defensins as biologically active proteins for treating infections and other diseases |
| 06/17/2004 | US20040116337 Soluble cyclic analogues of beta amyloid peptide |
| 06/17/2004 | US20040115789 Packaging cell lines for the continuous production of alphavirus vectors |
| 06/17/2004 | US20040115776 Increasing transcription efficiency of blood coagulation factor via fusion to sequences of scaffold/matrix attachment regions (SMAR); genetic engineering and gene transfer |
| 06/17/2004 | US20040115774 Adjust pharmokinetics; ligation, binding, overlapping; nonimmunogenic; genetic engineering |
| 06/17/2004 | US20040115773 Serpin in bifidobacteria |
| 06/17/2004 | US20040115772 Methods of inhibiting Helicobacter pylori |
| 06/17/2004 | US20040115768 including culturing the cells at a temperature below 37 degrees C in a solution of mannose, galactose, or fructose; solution may be serum-free; genetic engineering |
| 06/17/2004 | US20040115767 Immunogenic cell surface proteins of helicobacter pylori |
| 06/17/2004 | US20040115766 Using thermophilic microorganisms as bioreactors for generating polypeptides for use treament of skin disorders; antitumor agens; antiaging agents |
| 06/17/2004 | US20040115760 Method and device for carrying out biochemical reactions with a high throughput |
| 06/17/2004 | US20040115695 Methods for generating enhanced antibody producing cell lines with improved growth characteristics |
| 06/17/2004 | US20040115682 Comprises nucleotide sequences coding membrane protein associated with modifying low density lipoproteins for diagnosis and treatment of cardiovascular disorders |
| 06/17/2004 | US20040115619 Immunoglobulin which binds hepatitis c viral envelope proteins and prevents and treats viral diseases; immunotherapy; viricides |
| 06/17/2004 | US20040115218 Ubiquitin fusion-based vaccine system |
| 06/17/2004 | US20040115202 monospecific antibody which specifically binds an epitope of a mammalian DPPIV (dipeptidyl peptidase IV, also known as CD26). |
| 06/17/2004 | US20040115199 Method for down-regulating osteoprotegerin ligand activity |
| 06/17/2004 | US20040115130 Methods using O6 -alkyguanine-dna alkyltransferases |
| 06/17/2004 | DE10255508A1 Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen A method for culturing cells for the production of substances |
| 06/17/2004 | CA2706873A1 Modified neomycin-phosphotransferase gene that increases expression rates of co-integrated gene and uses thereof |
| 06/17/2004 | CA2508519A1 Recombinant immunotoxin and use in treating tumors |
| 06/17/2004 | CA2507711A1 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
| 06/17/2004 | CA2506629A1 Modified antibodies stably produced in milk and methods of producing same |
| 06/17/2004 | CA2469724A1 Mutant glycoproteins |
| 06/16/2004 | EP1428883A1 Megakaryocyte stimulating factors |
| 06/16/2004 | EP1428877A1 Novel protein and dna thereof |
| 06/16/2004 | EP1428873A2 Method for producing y-glutamylcysteine |
| 06/16/2004 | EP1428835A1 Antibody and use of the same |
| 06/16/2004 | EP1428834A1 Ligands for flt3 receptors |
| 06/16/2004 | EP1427841A2 Nucleic acid-associated proteins |
| 06/16/2004 | EP1427831A1 Yeast membrane protein expression system and its application in drug screening |
| 06/16/2004 | EP1427828A2 Random integration of a polynucleotide after in vivo linearization |
| 06/16/2004 | EP1427820A2 Modified factor ix |
| 06/16/2004 | EP1427819A2 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
| 06/16/2004 | EP1427815A2 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture |
| 06/16/2004 | EP1427806A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 06/16/2004 | EP1427758A2 Compositions and methods of treating diabetes |
| 06/16/2004 | EP1427753A2 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications |
| 06/16/2004 | EP1427751A2 Trk polypeptide purification method |
| 06/16/2004 | EP1427750A1 Modified transferrin fusion proteins |
| 06/16/2004 | EP1427744A2 A system for antibody expression and assembly |
| 06/16/2004 | EP1427432A2 Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives |
| 06/16/2004 | EP0881908B1 Use of fibroblast growth factors to stimulate bone growth |
| 06/16/2004 | EP0787299B1 Receptor for a bacillus thuringiensis toxin |
| 06/16/2004 | EP0667908B1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases |
| 06/16/2004 | EP0580737B1 Heterodimeric receptor libraries using phagemids |
| 06/16/2004 | CN1505679A Alkaline protease variants, and detergents and cleaning agents containing the same |
| 06/16/2004 | CN1504752A Vaughan Tristan J. |
| 06/16/2004 | CN1504574A Controlling T7 expression system by means of thermal induction |
| 06/16/2004 | CN1504566A Immunology epitope of hog cholera virus feature and application thereof |
| 06/16/2004 | CN1504483A NF-ª—B inhibitor, preparing process thereof and application as antineoplastic medicine |
| 06/16/2004 | CN1153780C Protein with thrombopoiesis substance activity |
| 06/15/2004 | US6750327 Compositions and method for determining the presence of human PTTG peptide in a sample |
| 06/15/2004 | US6750322 Guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
| 06/15/2004 | US6750199 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| 06/15/2004 | US6750056 Metal binding proteins and associated methods |
| 06/15/2004 | US6750045 Fermentation medium and method |
| 06/15/2004 | US6750043 Expression vector for use in the expression of heterologous protein in cells |
| 06/15/2004 | US6750041 Homologous recombination antibody expression system for murine cells |
| 06/15/2004 | US6750009 Multiple viral replicon culture systems |
| 06/15/2004 | US6749857 Recombinant dimeric envelope vaccine against flaviviral infection |
| 06/15/2004 | US6749847 Chemokine for use in of tumors |
| 06/15/2004 | CA2159330C Inhibition of leukocyte adhesion |
| 06/15/2004 | CA2049921C Allergenic proteins from ragweed and uses therefor |
| 06/10/2004 | WO2004048922A2 Bead-based detection of ligand-gpcr-g protein complexes |
| 06/10/2004 | WO2004048588A1 Process for purifying a fermentation-derived product |
| 06/10/2004 | WO2004048580A1 A method for marker-less integration of a sequence of interest into the genome of a cell |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048556A1 Method for culturing cells in order to produce substances |
| 06/10/2004 | WO2004048554A1 Cell extract of escherichia coli having mutation in s12 ribosomal protein and process for producing protein in cell-free system using the same |
| 06/10/2004 | WO2004048409A2 Mutants of the tumor necrosis factor alpha with deletion of n-terminal amino acids |
| 06/10/2004 | WO2004047762A2 Methods for treating cancer using porimin as a target |
| 06/10/2004 | WO2004047728A2 Compositions and methods for the treatment of immune related diseases |
| 06/10/2004 | WO2004022720A8 Methods for identifying antimicrobial compounds |
| 06/10/2004 | WO2004017810A3 Tumor specific oligosaccharide epitopes and use thereof |
| 06/10/2004 | WO2004010957A3 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 06/10/2004 | WO2003089641A3 Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems |
| 06/10/2004 | WO2003089571A3 Ehrlichia canis genes and vaccines |
| 06/10/2004 | WO2003084472A3 Recombinant p. falciparum merozoite protein-142 vaccine |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003054188A3 Seminal vesicle tissue-specific promoters and uses thereof |
| 06/10/2004 | WO2003040170A9 Antibodies to cd40 |
| 06/10/2004 | WO2003026689A8 Autologous growth factor cocktail composition, method of production and use |
| 06/10/2004 | US20040111769 Sugar beet genes involved in stress tolerance |
| 06/10/2004 | US20040110941 by cloning, amplifying and expressing DNA sequences using polymerase chain reaction; for therapy, diagnosis or catalysis; solid phase synthesis |
| 06/10/2004 | US20040110935 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 06/10/2004 | US20040110934 Human mitochondrial proteins and polynucleotides encoding the proteins |